Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
Recruiting · NCT05352178 · Registry updated 2024-07-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Metastasis-directed Therapy for Oligorecurrent Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic malignant neoplasm, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 3 | 2024-07-03 | NCT05352178 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Universitaire Ziekenhuizen KU Leuven | 262 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Hospitals Leuven | Leuven | Belgium | 14 |